Combined with L-Dopa, Remepy’s Hybrid Drug for PD provides digital interventions that address fine and gross motor skills, speech therapy, cognition, sleep, stress reduction, attention training, and psychoeducation. The patient experience includes a multidisciplinary care team guiding the patient through the daily activities and reminders to take the medication. The digital protocol is personalized and adapts to each patient progress and needs.
Learn more about Hybrid Drugs and about Remepy’s Hybrid Drug for Parkinson’s Disease
